- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1912
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Repurposing mesalazine against cardiac fibrosis in vitro ; day:16 ; month:10 ; year:2020 ; pages:1-11
Naunyn-Schmiedeberg's archives of pharmacology ; (16.10.2020), 1-11
- Urheber
-
Hoffmann, Maximilian
Kant, Theresa A.
Emig, Ramona
Rausch, Johanna S. E.
Newe, Manja
Schubert, Mario
Künzel, Karolina
Winter, Luise
Klapproth, Erik
Peyronnet, Remi
Ravens, Ursula
El-Armouche, Ali
Künzel, Stephan R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00210-020-01998-9
- URN
-
urn:nbn:de:101:1-2020113018335476083527
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hoffmann, Maximilian
- Kant, Theresa A.
- Emig, Ramona
- Rausch, Johanna S. E.
- Newe, Manja
- Schubert, Mario
- Künzel, Karolina
- Winter, Luise
- Klapproth, Erik
- Peyronnet, Remi
- Ravens, Ursula
- El-Armouche, Ali
- Künzel, Stephan R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Repurposing mesalazine against cardiac fibrosis in vitro
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
Drug repurposing
Data-driven host-directed antiviral drug repurposing against emerging pathogens
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
Repurposing mesalazine against cardiac fibrosis in vitro
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
Drug repurposing
Data-driven host-directed antiviral drug repurposing against emerging pathogens
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
Repurposing mesalazine against cardiac fibrosis in vitro
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
Drug repurposing
Data-driven host-directed antiviral drug repurposing against emerging pathogens